MOREPENLAB2026-09-02MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain1MOREPENLAB2026-09-02ResolutionOrAgendaDomain1MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain2MOREPENLAB2026-09-02ResolutionOrAgendaDomain2MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain3MOREPENLAB2026-09-02ResolutionOrAgendaDomain3MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain4MOREPENLAB2026-09-02ResolutionOrAgendaDomain4MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain5MOREPENLAB2026-09-02ResolutionOrAgendaDomain5MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain6MOREPENLAB2026-09-02ResolutionOrAgendaDomain6MOREPENLAB2026-09-022026-09-02ResolutionOrAgendaDomain7MOREPENLAB2026-09-02ResolutionOrAgendaDomain7iso4217:INRxbrli:pureMOREPENLABMOREPEN LABORATORIES LIMITEDNew2026-09-0213:00:002026-09-02Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)41st Annual General MeetingSaturday2026-09-2613:00:00Deemed venue of the meeting is the Registered Office of the Company.7Notes <BR> <BR> 1. The members of the Company, at the 40th Annual General Meeting held on 6 September 2025, approved the re-appointment of Mr. Sanjay Suri as Whole-time Director for a period of 3 years commencing from 13 August 2025 and ending on 12 August 2028. Subsequently, the Board of Directors, at its meeting held on 30 June 2026, recommended and approved the elevation and change in designation of Mr. Sanjay Suri from “Whole-time Director” to “Managing Director”, with effect from 1 July 2026, <BR> <BR> The XBRL utility mandatorily requires the disclosure of Tenure Start Date and Tenure End Date. Accordingly, the Tenure Start Date has been reported as 1 July 2026, being the effective date of change in designation of Mr. Sanjay Suri from Whole-time Director to Managing Director, and the Tenure End Date as 12 August 2028, being the end date of his existing term approved by the members. <BR> <BR> Further, as the XBRL utility also mandatorily requires disclosure of the term of appointment, “3 years” has been selected in the drop-down, corresponding to the term originally approved by the members at the 40th AGM. <BR> <BR> 2. Item No. 5 of the Notice includes the proposal for approval of remuneration payable to Mr. Sanjay Suri, Managing Director, up to Rs. 14 crore and Item No. 6 includes the proposal for approval of remuneration payable to Mr. Sushil Suri, Chairman & Managing Director, up to Rs. 16.50 crore. <BR> <BR> Ordinary ResolutionAdoption of Financial StatementsTo receive, consider and adopt the audited financial statements, including consolidated financial statements, of the company for the financial year ended 31 March 2026 together with the reports of the Directors and Auditors thereon.Ordinary ResolutionIssuance/Corporate ActionDividendTo declare the final dividend of Rs. 0.20/- per equity share of the face value of Rs. 2 each, for the financial year ended 31 March 2026.Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRetirement by rotationTo appoint a director in place of Mr. Sanjay Suri (DIN: 00041590), who retires by rotation at this Annual General Meeting and being eligible, offers himself for re-appointment.Executive DirectorSanjay Suri000415902026-09-262026-09-26Ordinary ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRemunerationRatification of remuneration of M/s. Vijender Sharma & Co., Cost Accountants, as Cost Auditors of the company.OthersVijender Sharma & Co.Vijender Sharma2026-04-012027-03-31250000Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationAppointmentElevation and change in designation of Mr. Sanjay Suri (DIN: 00041590) from Whole-Time Director to Managing DirectorExecutive DirectorSanjay Suri000415902026-07-012028-08-123Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRe-appointmentRe-appointment of Mr. Sushil Suri (DIN: 00012028) as the Chairman & Managing DirectorExecutive DirectorSushil Suri000120282026-10-202029-10-193Special ResolutionOthersOthersOthersExtension of approved timeline for hiving off Medical Devices Business of the Company, a material related party transaction, into Morepen Medipath Limited (formerly, Morepen Medtech Limited), subsidiary company as a going concern on slump sale basis.